Sean Harper
Angel Investor @ Westlake Village BioPartners
Chicago, United States
Sean Harper is a seed investor at Westlake Village BioPartners in Chicago focused on Enterprise Software and FinTech. Sean Harper is based out of Twin Lakes, Wisconsin, and is the Strategic Advisory Board Member of Orange Auto Insurance and also served as a CEO and Co Founder of Kin Insurance. Sean previously worked at Accion as a Board Member. Sean Harper attended The University of Chicago Booth School of Business.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 20%
Last updated:
For AI agents: llms.txt
Industries Sean Harper invests in
Stages Sean Harper invests in
Countries Sean Harper invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $800k–$19M
- Pre-Seed
- $1.4M–$2.2M
Investment Focus
Industry
- Enterprise Software 3 (30%)
- FinTech 2 (20%)
- Software 2 (20%)
- InsurTech 2 (20%)
- Financial Services 2 (20%)
Stage
- Seed 4 (40%)
- Pre-Seed 2 (20%)
- Series A 1 (10%)
- Series B 1 (10%)
- Series C 1 (10%)
Country
- United States 4 (40%)
- Mexico 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Qumis is an AI-powered knowledge platform built by insurance coverage experts to be indispensable to the daily lives of complex claims teams. We use the power of large language models to turn any insurance policy into a live, citation enriched document empowered by the collective expertise of your team and our proprietary database of court records.Qumis was designed from the ground up to have enterprise-grade data security, frictionless implementation and ease of use, and truly transformative effects on complex claims teams. We are on a mission to accelerate the business of insurance and use technology to give claims professionals more time to focus on what is important to them. | $2.2M / Pre-Seed / Jan 21, 2025 | ||
| Meanwhile is a licensed and regulated life insurance business. | $19M / Seed / Jun 06, 2023 | ||
| ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients. | $300M / Series C / Sep 13, 2022 | ||
| Uprise is building wealth management for all - bringing the tools and the tricks of the 1% to everyone :). The company was founded by Chris Goodmacher and Jessica Chen Riolfi. | $1.4M / Pre-Seed / Jul 11, 2022 | ||
| ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients. | $250M / Series B / Nov 16, 2021 | ||
| Anzen is a management insurance and operations tool using real-time HRIS and SaaS integrations to identify and avoid management risks. The company was founded in 2020 and is headquartered in San Francisco, California, United States. | Seed / Aug 25, 2021 | ||
| ACELYRIN is a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of promising drug candidates and by leveraging its expertise to rapidly advance these medicines to patients. | $8M / Series A / Dec 15, 2020 | ||
| Conekta designs an online payment platform that helps banks and financial institutions secure and optimize their processes. Its platform uses artificial intelligence to integrate the API, so that it can process online and offline payments, enabling financial institutions to analyze the transaction behavior to identify fraudulent purchases while itsPCI-DSS certified secure banking services encrypt and protect banking and financial information. | $1.8M / Seed / May 01, 2015 | ||
| WeDeliver connects businesses to their customers by providing same-day delivery of goods, real-time tracking and customer feedback. Using a fleet of curated, on-demand drivers powered by algorithmic dispatching, the company ensures the quickest delivery of any product from any business to any customer at any time. | $800K / Seed / Jan 15, 2014 | ||
| See all 10 investments → | |||
Co-Investors
Westlake Village BioPartners is a venture capital firm focused on incubating and building life sciences companies with entrepreneurs that have the potential to bring transformative therapies and technologies to patients. The Westlake model is built on the founding team’s unique experience in successfully identifying and developing breakthroughtherapies and building organizations.
Westlake Village BioPartners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Sean E. Harper
Managing Partner
|
|||
Beth Seidenberg
Managing Director
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sean Harper invest in?
Sean Harper invests primarily in Enterprise Software, FinTech and Software startups, most often at Seed and Pre-Seed stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Sean Harper invest in?
Sean Harper typically joins rounds of $800k–$19M at Seed and $1.4M–$2.2M at Pre-Seed. These are whole funding-round sizes, not Sean Harper's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Sean Harper took part in.
How do I contact Sean Harper?
Public channels for Sean Harper include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Sean Harper last invest?
The most recent investment recorded for Sean Harper closed in Jan 2025. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
